Notice: Passwords are now case-sensitive
Forgot your password? Register a new account



Community Requests

Researchers: Study Used in FDA Approval of Zohydro Offered scant Evidence of Efficacy

Tuesday, March 10, 2015 | 1443 | 0 | 0 min read

Zohydro ER, a controversial long-acting opioid that hit the market last year to cries of outrage, received government approval on the heels of a study with dubious conclusions as to the drug’s effectiveness at relieving pain, researchers have concluded. (image via When the U.S...

Purchase this story for only $9.16!Add to Cart

For access to all of our articles, check out our subscription options.


Be the first to comment.

Related Articles